Article

FAT10 Combined with Miltefosine Inhibits Mitochondrial Apoptosis and Energy Metabolism in…

Evidence-Based Complementary and Alternative Medicine · 2022 · Yi Yao, author Weikun Jia, author Xiaofei Zeng, author Yali Wang, author Qiuxia Hu, author Shiran Yu, author Dongsheng He, author Ying Li, author Hao Luo, Academic Editor

Key facts

Title FAT10 Combined with Miltefosine Inhibits Mitochondrial Apoptosis and Energy Metabolism in Hypoxia-Induced H9C2 Cells by Regulating the PI3K/AKT Signaling Pathway
First author Yi Yao, author Weikun Jia, author Xiaofei Zeng, author Yali Wang, author Qiuxia Hu, author Shiran Yu, author Dongsheng He, author Ying Li, author Hao Luo, Academic Editor
Journal Evidence-Based Complementary and Alternative Medicine
Published May 12, 2022
DOI 10.1155/2022/4388919
Devices mentioned 012419

At a glance

  • 1–9 FDA submissions mentioned
  • None Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature